Compare Tempus AI (TEM) vs US Bancorp (USB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tempus AI vs US Bancorp — how do they compare? Tempus AI trades at $61.18 (market cap $11.67B), while US Bancorp trades at $62 (market cap $97.36B). The key difference: US Bancorp is far larger — about 8.3× Tempus AI's market cap, and US Bancorp pays a 3.33% dividend while Tempus AI pays none. Which is the better fit depends on your goals.
| TEM | USB | |
|---|---|---|
Market Cap | $11.67B | $97.36B |
Sector | Broad Market / Factor | Financials |
52-Week High | $103.25 | $65.42 |
52-Week Low | $41.55 | $45.28 |
Enterprise Value | $12.30B | — |
Dividend Yield | — | 3.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Tempus AI (TEM) trades at $64.29, down 0.51% on the day, with a bullish technical signal and strong analyst support. The stock shows consistent earnings beats despite negative profitability, with a P/S of 7.99 and P/B of 26.23. Recent catalysts include FDA clearance for an AI ECG product and a $9.5 million ARPA-H award for autonomous AI in cardiology (Business Wire, September 9, 2026).
Outlook remains positive given analyst consensus and growth in precision medicine, but risks include sustained losses, high valuation multiples, and cash burn. The consensus price target is $69.11, implying potential upside, though investors must weigh the company's unprofitability against its innovation pipeline and market position.
U.S. Bancorp (USB) trades at $62.49, down 1.39% today, with a bearish technical signal and neutral oscillators. The stock shows strong fundamentals with a P/E of 12.47 and net income margin of 27.61%, supported by three consecutive quarterly EPS beats. Recent news highlights innovation in digital payments and business banking expansion. Cash flow trends indicate volatility, with 2025 net cash flow negative at -$9.61 billion.
The outlook is mixed: analyst consensus targets $70.27 (12.4% upside) with 50% buy ratings, but technicals suggest near-term pressure. Key risks include debt levels and macroeconomic sensitivity. Earnings growth and dividend stability ($0.52 quarterly) provide support, though investor sentiment is cautious amid market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →About US Bancorp
As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in well over 20 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.
Read more on USB →
